Kaya Limited · NSE:KAYA
Kaya — Q3 FY17 Earnings Presentation
21 slides from Kaya's earnings presentation, December 2016
Slide 1: Quarterly Performance Update Q3 FY-17
Quarterly Performance Update Q3 FY-17 Kaya Limited 1
Slide 2: Disclaimer
Disclaimer This investor presentation has been prepared by Kaya Limited (“Kaya”) and does not constitute a prospectus or placement memorandum or an offer to acquire any securities. This presentation or any other documentation or information (or any part thereof) delivered or supplied should not be d
Slide 3: Kaya Group: Key Highlights – Q3 FY 17
Kaya Group : Key Highlights – Q3 FY 17 • Net Revenue (NR) for Q3 FY 17 at INR 972 Mn has grown by 2%. Same store growth (SSG: -1%) • SSG @ constant currency is -3% • EBIDTA of INR -ve 7 Mn (-1% of NR) compared to EBIDTA of INR 49 Mn (5% of NR) in Q3 FY 16 • PAT at INR -ve 34 Mn (-4% of NR) as compar
Slide 4: Financial Summary – Q3 FY17
Financial Summary – Q3 FY17 Net Revenue (INR Mn) EBIDTA (INR Mn) Q3 FY 17 972 Q3 FY 17 (7) 114% 2% Q3 FY 16 952 Q3 FY 16 49 0 300 600 900 1200 -8 7 22 37 52 PAT Margin % EBIDTA Margin % Q3 FY 17 -4% Q3 FY 17 -1% Q3 FY 16 4% Q3 FY 16 5% -5% -3% -1% 1% 3% 5% -2% 0% 2% 4% 6% 4
Slide 5: Awards & Recognition
Awards & Recognition Kaya India - •“Asian Social Media & Digital Marketing Leadership Awards – CMO Asia” Award for Best Use of Social Media category. •“Star Retailer's Awards 2016 - Franchise India” Award for Specialty Retailer of the Year, Best Loyalty Solution/Service Provider of the Year KME - “R
Slide 6: Kaya India Region
TO | Kaya India Region kaya”
Slide 7: Kaya India: Key Highlights
Kaya India : Key Highlights • Net Revenue for Q3 FY 17 at INR 456 Mn de-grew by 4% (SSG: -7%) • KSB - grew by 42% over PY • Ecommerce:- grew by 25% over Q3 LY • EBIDTA at INR (55) Mn ( - 12% of NR) compared to EBIDTA of INR (21) Mn ( - 4% to NR) in Q3 LY • PAT is INR (59) Mn ( - 13% of NR) against I
Slide 8: Our Presence in India
Our Presence in India 102 Clinics 127 Kaya Skin Bars 27 Cities 16 Indian states Opened in Q3 FY 17 1 SIS -KSB Closed in Q3 FY 17: 1 Clinic 1 KSB CoCo / 1 SIS 8 The picture above just gives an idea of location and don’t represent exact scale
Slide 9: Operational Indicators – India (Clinics + E Com)
Operational Indicators – India (Clinics + E Com) 64000 60,077 8000 7,713 60000 58,615 7,495 56000 7000 52000 2% 6000 3% 2% 48000 44000 5000 40000 4000 Q3 FY 16 Q3 FY 17 Q3 FY 16 Q3 FY 17 Customer count Ticket Size (Rs) • Customer Count degrew by 2% (SSG: -3%) • Ticket Size grew by 3% over LY. (SSG:
Slide 10: Category Mix % - India (Clinics + E Com)
Category Mix % - India (Clinics + E Com) 6% 80% 71% 67% 70% 60% 50% -5% 40% -18% 30% 20% 19% 20% 13% 11% 10% 0% Cure Care Products Q3 FY 16 Q3 FY 17 • Cure category grew by 6% (SSG: 2%) in Q3 FY 17 • Hair Free category is driving the major growth • Care vertical de-grew by 18% (SSG: -ve 20%) in Q3 F
Slide 11: Kaya Middle East Region
7 | Kaya Middle East Region kaya
Slide 12: Kaya Middle East: Key Highlights
Kaya Middle East : Key Highlights • Net Revenue at INR 516 Mn for Q3 FY 17 has grown by 8%. Same store growth (SSG : 6%). • SSG @ constant currency for Q3 FY 17 is 1% • On SSG basis Ticket size grew by 4% & Customer count has de-grown by 8%; over Q3 FY 16 • EBIDTA of INR 48 Mn (9% of NR) compared to
Slide 13: Our Presence in GCC
Our Presence in GCC… 21 Clinics 4 Countries 10 Cities 13 The picture above iust gives an idea of location and don’t represent exact scale
Slide 14: Operational Indicators – Middle East
Operational Indicators – Middle East 18000 17017 460 447 16678 440 433 16000 420 2% 400 3% 14000 380 360 12000 340 320 10000 300 Q3 FY 16 Q3 FY 17 Q3 FY 16 Q3 FY 17 Customer count Ticket Size (USD) • Customer count de-grew by 2% (SSG: -8%) over Q3 LY. • Ticket size growth is 3% (SSG: 4%) over Q3 LY
Slide 15: Category Mix % - KME Region
Category Mix % - KME Region -2% 90% 83% 81% 80% 70% 60% 50% 16% 40% 30% 15% 20% 11% 8% 10% 10% 7% 0% Cure Care Products Q3 FY 16 Q3 FY 17 • Cure category de-grew by 2% (SSG: -ve 8%) in Q3 FY 17. • Hair free technology scale up in all clinics helped to drive growth. • Care vertical grew by 15% (SSG:
Slide 16: Financials – Q3 FY 17
Financials – Q3 FY 17 16
Slide 17: Financial Highlights: Kaya Group
Financial Highlights : Kaya Group Particulars (INR Mn) Q3 FY 16 Q3 FY 17 Collection SSG -1% -3% @ constant currency Collection 964 1006 4% Net Revenue SSG -1% -3% @ constant currency Net Revenue 952 972 2% EBIDTA is -1% , against 5% LY EBIDTA 49 -7 Operating margin at -6%, Operating Margin 8 -56 aga
Slide 18: Financial Highlights: India
Financial Highlights : India Particulars (INR Mn) Q3 FY 16 Q3 FY 17 Collection SSG (Clinics) -1% Collection 480 496 3% Net Revenue SSG (Clinics) -7% Net Revenue 476 456 4% EBIDTA margin at - 12 % EBIDTA -21 -55 against - 4% of Q3 LY Operating margin at - 18% Operating Margin -46 -82 against - 10 % Q
Slide 19: Financial Highlights: Middle East
Financial Highlights : Middle East Particulars (INR Mn) Q3 FY 16 Q3 FY 17 Collection SSG -1% -5% @ constant currency Collection 484 510 5% Net Revenue SSG 6% 8% 1% @ constant currency Net Revenue 476 516 EBIDTA margin at 9% against 15% Q3 LY EBIDTA 70 48 Operating Margin 54 26 Operating margin at 5%
Slide 20: Contact for clarifications
In case of any clarifications please contact on investorrelations@kayaindia.net 20
Slide 21: Thank you
Thank you 21